Experience with DPP-4 inhibitors in the management of patients with type 2 diabetes fasting during Ramadan

Experience with DPP-4 inhibitors in the management of patients with type 2 diabetes fasting during Ramadan

Anja Schweizer,1 Serge Halimi,2,3 Sylvie Dejager4 1Novartis Pharma AG, Basel, Switzerland; 2Department of Diabetology, Endocrinology and Nutrition, University Hospital of Grenoble, France; 3Joseph Fourier University, Grenoble, France; 4Novartis Pharma SAS, Rueil-Malmaison, France Abstract: A large...

Full description

Bibliographic Details
Main Authors: Schweizer A, Halimi S, Dejager S
Format: Article
Language:English
Published: Dove Medical Press 2013-12-01
Series:Vascular Health and Risk Management
Online Access:http://www.dovepress.com/experience-with-dpp-4-inhibitors-in-the-management-of-patients-with-ty-a15372

Internet

http://www.dovepress.com/experience-with-dpp-4-inhibitors-in-the-management-of-patients-with-ty-a15372

Similar Items